Personalis, Inc. (PSNL)
USD 3.79
(2.99%)
USD 3.79
(2.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -96.8 Million USD | 24.83% |
| 2022 | -104.64 Million USD | -73.89% |
| 2021 | -59.01 Million USD | -83.37% |
| 2020 | -34.05 Million USD | -59.47% |
| 2019 | -18.21 Million USD | -112.93% |
| 2018 | -14.91 Million USD | 50.44% |
| 2017 | -21.07 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -14.09 Million USD | 1.28% |
| 2024 Q1 | -16.04 Million USD | 57.25% |
| 2023 Q2 | -20.87 Million USD | 4.8% |
| 2023 Q3 | -23.49 Million USD | -12.51% |
| 2023 FY | - USD | 24.83% |
| 2023 Q1 | -21.93 Million USD | 29.28% |
| 2023 Q4 | -17.02 Million USD | 27.52% |
| 2022 Q3 | -24.55 Million USD | 4.32% |
| 2022 FY | - USD | -73.89% |
| 2022 Q1 | -26.36 Million USD | -30.91% |
| 2022 Q4 | -31.01 Million USD | -26.31% |
| 2022 Q2 | -25.66 Million USD | 2.68% |
| 2021 FY | - USD | -83.37% |
| 2021 Q1 | -10.88 Million USD | 8.11% |
| 2021 Q4 | -20.14 Million USD | -25.16% |
| 2021 Q3 | -16.09 Million USD | -8.16% |
| 2021 Q2 | -14.88 Million USD | -36.71% |
| 2020 FY | - USD | -59.47% |
| 2020 Q4 | -11.84 Million USD | -46.66% |
| 2020 Q3 | -8.07 Million USD | -3.12% |
| 2020 Q2 | -7.83 Million USD | -1.57% |
| 2020 Q1 | -7.71 Million USD | -16.11% |
| 2019 Q3 | -3.78 Million USD | -39.76% |
| 2019 Q1 | -4.31 Million USD | -108.8% |
| 2019 Q2 | -2.7 Million USD | 37.26% |
| 2019 Q4 | -6.64 Million USD | -75.41% |
| 2019 FY | - USD | -112.93% |
| 2018 Q1 | -4.63 Million USD | 0.0% |
| 2018 Q3 | -832 Thousand USD | 71.42% |
| 2018 Q4 | -2.06 Million USD | -148.56% |
| 2018 FY | - USD | 50.44% |
| 2018 Q2 | -2.91 Million USD | 37.17% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 17.657% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -909.348% |
| Aspira Women's Health Inc. | -16.49 Million USD | -487.029% |
| Biodesix, Inc. | -37.1 Million USD | -160.914% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -3795.402% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -1168.884% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -1168.884% |
| Bionano Genomics, Inc. | -213.6 Million USD | 54.679% |
| CareDx, Inc | -89.65 Million USD | -7.975% |
| Check-Cap Ltd. | -17.64 Million USD | -448.513% |
| Castle Biosciences, Inc. | -45.02 Million USD | -115.012% |
| DarioHealth Corp. | -53.49 Million USD | -80.968% |
| Exact Sciences Corporation | 41.87 Million USD | 331.175% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -107.955% |
| Guardant Health, Inc. | -433.3 Million USD | 77.658% |
| ICON Public Limited Company | 1.63 Billion USD | 105.933% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 107.95% |
| Illumina, Inc. | -608 Million USD | 84.078% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -998.743% |
| iSpecimen Inc. | -9.1 Million USD | -963.378% |
| Standard BioTools Inc. | -54.45 Million USD | -77.768% |
| MDxHealth SA | -30.46 Million USD | -217.733% |
| 23andMe Holding Co. | -291.87 Million USD | 66.833% |
| Medpace Holdings, Inc. | 363.15 Million USD | 126.657% |
| Myriad Genetics, Inc. | -67.8 Million USD | -42.783% |
| Mainz Biomed B.V. | -25.01 Million USD | -287.055% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -889.361% |
| NeoGenomics, Inc. | -17.6 Million USD | -449.821% |
| Neogen Corporation | 182.59 Million USD | 153.017% |
| Inotiv, Inc. | -26.5 Million USD | -265.227% |
| Natera, Inc. | -383.27 Million USD | 74.742% |
| OpGen, Inc. | -29.51 Million USD | -228.037% |
| OPKO Health, Inc. | -65.51 Million USD | -47.761% |
| Psychemedics Corporation | -251 Thousand USD | -38468.526% |
| Prenetics Global Limited | -47.89 Million USD | -102.119% |
| Prenetics Global Limited | -47.89 Million USD | -102.119% |
| Precipio, Inc. | -4.31 Million USD | -2141.941% |
| RadNet, Inc. | 292.78 Million USD | 133.064% |
| Sera Prognostics, Inc. | -35.28 Million USD | -174.342% |
| Sotera Health Company | 514.14 Million USD | 118.829% |
| Neuronetics, Inc. | -22.75 Million USD | -325.357% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -5638.411% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -5638.411% |
| Trinity Biotech plc | -24.09 Million USD | -301.722% |
| T2 Biosystems, Inc. | -43.87 Million USD | -120.643% |
| Twist Bioscience Corporation | -176.7 Million USD | 45.215% |
| Exagen Inc. | -19.15 Million USD | -405.44% |